From the Guidelines
If you've experienced a seizure after having COVID-19, you should seek immediate medical attention through your primary care physician or an emergency department. Post-COVID seizures have been reported and may be related to neurological complications of the infection, as highlighted in a recent study published in Nature Reviews Microbiology 1. This study found that cognitive impairment, seizures, dementia, psychosis, and other neurocognitive conditions persisted for at least 2 years after COVID-19 infection.
Key Considerations
- The exact cause of post-COVID seizures is not fully understood, but possible mechanisms include neuroinflammation, damage to blood vessels, and injury to neurons 1.
- A neurologist will likely perform tests including an EEG (electroencephalogram), brain imaging (MRI or CT scan), and blood tests to determine the cause and appropriate treatment.
- Common anti-seizure medications that might be prescribed include levetiracetam (Keppra), lamotrigine (Lamictal), or valproic acid (Depakote), typically starting at lower doses and adjusting as needed.
Safety Precautions
- While awaiting medical care, ensure your safety by avoiding driving, operating machinery, swimming alone, and create a safe environment by removing sharp objects and furniture with hard edges from your surroundings.
- It is essential to work with a healthcare provider to develop a personalized treatment plan, as treatment depends on the type of seizure, medical history, and other factors. COVID-19 can affect the nervous system through direct viral invasion, inflammatory responses, or blood clotting abnormalities, which may trigger seizures in some individuals 1.
From the Research
Post Covid Seizure Overview
- Post Covid seizure is a potential complication of COVID-19, with some patients experiencing seizures after recovery from the initial infection 2.
- Seizures can occur in patients with COVID-19, particularly those with severe cases or underlying neurological conditions 3, 4.
- The management of seizures in COVID-19 patients may require careful consideration of antiepileptic drug interactions and potential side effects 3, 5, 6.
Seizure Management in COVID-19 Patients
- Levetiracetam, midazolam, and sodium valproate are commonly used antiepileptic drugs in the management of seizures in COVID-19 patients 3.
- Midazolam may be effective in preventing recurrent seizures in COVID-19 patients, with no reported cases of recurrent seizures in patients receiving this medication 3.
- Patients with COVID-19 who experience seizures may require close monitoring and adjustment of their antiepileptic medication regimen to minimize the risk of recurrent seizures and other complications 3, 6.
Post Covid Seizure as a "Long-COVID" Complication
- Post Covid seizure can be a feature of "long-COVID", with some patients experiencing seizures weeks or months after initial recovery from COVID-19 2.
- The exact mechanisms underlying post Covid seizure are not fully understood, but may be related to the neurotropic and neuroinvasive capabilities of SARS-CoV-2 2, 4.
- Further research is needed to understand the incidence, risk factors, and optimal management of post Covid seizure as a "long-COVID" complication 2.